The 2026 J.P. Morgan Healthcare Conference revealed a decisive shift in how the industry approaches artificial intelligence. No

Artificial intelligence is transforming oncology through dual capabilities: mapping population-level cancer survival patterns to reveal systemic inequities, and

Major tech companies and academic institutions are converging on a new approach to healthcare AI: tools designed to